Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 38

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 38
---
 with the Enterprise Registrar under the QBCA the Articles 
 of Arrangement as soon as reasonably practicable and in any event within five Business Days after the satisfaction or waiver of the conditions to the completion of the Arrangement. For more information, you should read “Court Approval of            
 the Arrangement.”                                                                                                                                                                                                                                        |

| Q: | How will I know when the Arrangement will be implemented? |

The Effective Date could be delayed or not occur at all for a number of reasons, including, but not limited to, an objection before the Court at the hearing of the application for the Final Order or any delay or failure in satisfying the conditions to the completion of the Arrangement, including obtaining Shareholder approval at the Special Meeting.

| Q: | What will happen if the Arrangement is not consummated? |

| A: | If the Arrangement is not consummated for any reason, the Shareholders will not receive any                                                                                                                                                     
 Consideration for their Common Shares in connection with the Arrangement. Instead, if the Liquidation Resolution is approved by Shareholders, the Company will proceed with the Liquidation. For more information, you should read “Liquidation 
 Resolution and Liquidator Resolution.”                                                                                                                                                                                                          |

18

| Q: | What do I need to do now? |

| A: | We urge you to read this Circular and Proxy Statement carefully, including its annexes and the documents                                           
 referred to as incorporated by reference in this Circular and Proxy Statement filed with the SEC, and to consider how the Arrangement affects you. |

Registered Shareholders may deposit a proxy that nominates a Person or entity to represent the Shareholder at the Special Meeting. All proxies or alternative forms of proxy must be completed properly and signed, and deposited at the office of the Company’s registrar and transfer agent (Computershare) indicated on the enclosed envelope for receipt not later than 10:00 a.m. (Montreal time) on January 14, 2026 or, in the event that the Special Meeting is adjourned or postponed, 48 hours (excluding Saturdays, Sundays and holidays) before the adjusted time of the Special Meeting, or by delivering it to the chair of the Board, prior to the commencement of the Special Meeting on the date of such Special Meeting. Beneficial Shareholders should carefully follow the instructions set out in the Voting Instruction Form (the “ VIF”), including those regarding when and where the VIF is to be delivered. Should a Beneficial Shareholder who receives a VIF wish